PARODONTIT VA UNING ZAMONAVIY DAVOLASH USULLARI.

##article.authors##

  • Mingboeva Moxlaroyim Xolmurod qizi ##default.groups.name.author##

##semicolon##

Kalit so‘zlar: Parodontit, milk kasalligi, parodontal terapiya, lazerli davolash, regenerativ terapiya, antimikrob davolash.

##article.abstract##

Annotatsiya: Parodontit og‘iz gigiyenasi bilan bog‘liq jiddiy  kasallik bo‘lib, 
tishlarni  ushlab  turuvchi  to‘qimalarning  buzilishiga  olib  keladi.  Ushbu  maqolada 
parodontitning  patogeneziga  oid  ma'lumotlar,  uning  zamonaviy  davolash  usullari 
bo‘yicha  yangi  adabiyotlar  tahlili  va  zamonaviy  tadqiqotlardan  natijalar  ko‘rib 
chiqiladi. Munozarada yangi yondashuvlarning samaradorligi ta'kidlanib, kelajakdagi 
tadqiqotlar uchun tavsiyalar keltiriladi. 

##submission.citations##

Adabiyotlar.

1. Recent Advances of Therapeutic Targets for the Treatment of Periodontal Disease.

Woo Jin Kim, Yunjo Soh and Seok-Mo Heo. Biomol Ther (Seoul). 2021 May 1;

29(3): 263–267. doi: doi: 10.4062/biomolther.2021.001.

2. Loos B. G., Van Dyke T. E. The role of inflammation and genetics in periodontal

disease. Periodontol. 2000. 2020;83:26–39. doi: 10.1111/prd.12297.

3. Marchesan J. T., Girnary M. S., Moss K., Monaghan E. T., Egnatz G. J., Jiao Y.,

Zhang S., Beck J., Swanson K. V. Role of inflammasomes in the pathogenesis of

periodontal disease and therapeutics. Periodontol. 2000. 2020;82:93–114. doi:

10.1111/prd.12269.

4. Marchesan J. T., Jiao Y., Moss K., Divaris K., Seaman W., Webster-Cyriaque J.,

Zhang S., Yu N., Song C., Bencharit S., Teles R., Offenbacher S. Common

polymorphisms in IFI16 and AIM2 genes are associated with periodontal disease.

J. Periodontol. 2017;88:663–672. doi: 10.1902/jop.2017.160553.

5. Ominsky M. S., Vlasseros F., Jolette J., Smith S. Y., Stouch B., Doellgast G., Gong

J. H., Gao Y. M., Cao J., Graham K., Tipton B., Cai J., Deshpande R., Zhou L.,

Hale M. D., Lightwood D. J., Henry A. J., Popplewell A. G., Moore A. R., Robinson

M. K., Lacey D. L., Simonet W. S., Paszty C. Two doses of sclerostin antibody in

cynomolgus monkeys increases bone formation, bone mineral density, and bone

strength. J. Bone Miner. Res. 2010;25:948 959. doi: 10.1002/jbmr.14.

6. Padhi D., Jang G., Stouch B., Fang L. A., Posvar E. Single-dose, placebo-controlled,

randomized study of AMG 785, a sclerostin monoclonal antibody. J. Bone Miner.

Res. 2011;26:19–26. doi: 10.1002/jbmr.173.

7. Venkatramanan M., Sankar Ganesh P., Senthil R., Akshay J., Veera Ravi A.,

Langeswaran K., Vadivelu J., Nagarajan S., Rajendran K., Shankar E. M. Inhibition

of quorum sensing and biofilm formation in Chromobacterium violaceum by fruit

extracts of Passiflora edulis. ACS Omega. 2020;5:25605–25616. doi:

10.1021/acsomega.0c02483.

##submission.downloads##

##submissions.published##

2025-01-06